Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [12]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10314-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10314-1-AP, RRID:AB_2197546
- Product name
- Stanniocalcin 2 antibody
- Antibody type
- Polyclonal
- Description
- Stanniocalcin 2 antibody (Cat. #10314-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references The down-regulation of STC2 mRNA may serve as a biomarker for death from mechanical asphyxia.
Molecular characterization of Golgi apparatus-related genes indicates prognosis and immune infiltration in osteosarcoma.
Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma.
Stanniocalcin2 inhibits the epithelial-mesenchymal transition and invasion of trophoblasts via activation of autophagy under high-glucose conditions.
Five hypoxia and immunity related genes as potential biomarkers for the prognosis of osteosarcoma.
Addiction to Golgi-resident PI4P synthesis in chromosome 1q21.3-amplified lung adenocarcinoma cells.
The mRNA-miRNA-lncRNA Regulatory Network and Factors Associated with Prognosis Prediction of Hepatocellular Carcinoma.
Tumor suppressor functions of DAXX through histone H3.3/H3K9me3 pathway in pancreatic NETs.
Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma.
Clinical significance of stanniocalcin 2 expression as a predictor of tumor progression in gastric cancer.
Evaluation of protein expression pattern of stanniocalcin 2, insulin-like growth factor-binding protein 7, inhibin beta A and four and a half LIM domains 1 in esophageal squamous cell carcinoma.
Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
Hu Y, Han L, Zhang H, Li W, Wu T, Ma J, Zhang D, Ma K, Xiao B, Yu Y, Xu H, Tian L, Liao X, Chen L
Legal medicine (Tokyo, Japan) 2024 Mar;67:102382
Legal medicine (Tokyo, Japan) 2024 Mar;67:102382
Molecular characterization of Golgi apparatus-related genes indicates prognosis and immune infiltration in osteosarcoma.
Zhang J, Liu J, Ding R, Miao X, Deng J, Zhao X, Wu T, Cheng X
Aging 2024 Mar 7;16(6):5249-5263
Aging 2024 Mar 7;16(6):5249-5263
Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma.
Chen W, Liao Y, Sun P, Tu J, Zou Y, Fang J, Chen Z, Li H, Chen J, Peng Y, Wen L, Xie X
Journal of translational medicine 2024 Jan 16;22(1):66
Journal of translational medicine 2024 Jan 16;22(1):66
Stanniocalcin2 inhibits the epithelial-mesenchymal transition and invasion of trophoblasts via activation of autophagy under high-glucose conditions.
Lai R, Ji L, Zhang X, Xu Y, Zhong Y, Chen L, Hu H, Wang L
Molecular and cellular endocrinology 2022 May 1;547:111598
Molecular and cellular endocrinology 2022 May 1;547:111598
Five hypoxia and immunity related genes as potential biomarkers for the prognosis of osteosarcoma.
Liu D, Hu Z, Jiang J, Zhang J, Hu C, Huang J, Wei Q
Scientific reports 2022 Jan 31;12(1):1617
Scientific reports 2022 Jan 31;12(1):1617
Addiction to Golgi-resident PI4P synthesis in chromosome 1q21.3-amplified lung adenocarcinoma cells.
Shi L, Tan X, Liu X, Yu J, Bota-Rabassedas N, Niu Y, Luo J, Xi Y, Zong C, Creighton CJ, Glenn JS, Wang J, Kurie JM
Proceedings of the National Academy of Sciences of the United States of America 2021 Jun 22;118(25)
Proceedings of the National Academy of Sciences of the United States of America 2021 Jun 22;118(25)
The mRNA-miRNA-lncRNA Regulatory Network and Factors Associated with Prognosis Prediction of Hepatocellular Carcinoma.
Hu B, Ma X, Fu P, Sun Q, Tang W, Sun H, Yang Z, Yu M, Zhou J, Fan J, Xu Y
Genomics, proteomics & bioinformatics 2021 Dec;19(6):913-925
Genomics, proteomics & bioinformatics 2021 Dec;19(6):913-925
Tumor suppressor functions of DAXX through histone H3.3/H3K9me3 pathway in pancreatic NETs.
Ueda H, Akiyama Y, Shimada S, Mogushi K, Serizawa M, Matsumura S, Mitsunori Y, Aihara A, Ban D, Ochiai T, Kudo A, Tanabe M, Tanaka S
Endocrine-related cancer 2018 Jun;25(6):619-631
Endocrine-related cancer 2018 Jun;25(6):619-631
Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma.
Parris TZ, Kovács A, Aziz L, Hajizadeh S, Nemes S, Semaan M, Forssell-Aronsson E, Karlsson P, Helou K
International journal of cancer 2014 Apr 1;134(7):1617-29
International journal of cancer 2014 Apr 1;134(7):1617-29
Clinical significance of stanniocalcin 2 expression as a predictor of tumor progression in gastric cancer.
Arigami T, Uenosono Y, Ishigami S, Yanagita S, Hagihara T, Haraguchi N, Matsushita D, Hirahara T, Okumura H, Uchikado Y, Nakajo A, Hokita S, Natsugoe S
Oncology reports 2013 Dec;30(6):2838-44
Oncology reports 2013 Dec;30(6):2838-44
Evaluation of protein expression pattern of stanniocalcin 2, insulin-like growth factor-binding protein 7, inhibin beta A and four and a half LIM domains 1 in esophageal squamous cell carcinoma.
Kashyap MK, Pawar HA, Keerthikumar S, Sharma J, Goel R, Mahmood R, Kumar MV, Kumar KV, Pandey A, Kumar RV, Prasad TS, Harsha HC
Cancer biomarkers : section A of Disease markers 2012-2013;12(1):1-9
Cancer biomarkers : section A of Disease markers 2012-2013;12(1):1-9
Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
Meyer HA, Tölle A, Jung M, Fritzsche FR, Haendler B, Kristiansen I, Gaspert A, Johannsen M, Jung K, Kristiansen G
European urology 2009 Mar;55(3):669-78
European urology 2009 Mar;55(3):669-78
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human brain tissue were subjected to SDS PAGE followed by western blot with 10314-1-AP(STC2 antibody) at dilution of 1:500
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The Stanniocalcin 2 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human Stanniocalcin 2. This antibody recognizes human,mouse,rat antigen. The Stanniocalcin 2 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
